Elira Therapeutics
St. Louis, US · Founded 2015 · Delaware corporation
Founders & leadership
BJ
Bevil J HoggExecutive
LJ
Luis J. MalaveExecutive
Board
RE
Raul E. PerezBoard director
PV
Paul V. GoodeBoard director
Reported raises · per SEC filings
Form D private placements$14M disclosed across 9 rounds · 2015–2023
▶$3.4MraisedJun 2024 · 34 investors · Other Health CareRule 506(b)
▶$3.4MraisedJun 2024 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- C. David AdairDirector
- Jason A. DarrahExecutive Officer
- A. Travis SpitzerDirector
- Raul E. PerezExecutive Officer, Director
- Arda M. MinocherhomjeeDirector
- Offering amount
- $4.7M
- Amount sold
- $3.4M
- Minimum investment
- $400
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedDec 2022 · 19 investors · Other Health CareRule 506(b)
▶$1.3MraisedDec 2022 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- A. Travis SpitzerDirector
- Jason A. DarrahExecutive Officer
- Charlie BoltenDirector
- Arda M. MinocherhomjeeDirector
- C. David AdairDirector
- Raul E. PerezExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.3M
- Minimum investment
- $1K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJan 2021 · 24 investors · Other Health CareRule 506(b)
▶$1.6MraisedJan 2021 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- C. David AdairDirector
- Jason A. DarrahExecutive Officer
- Charlie BoltenDirector
- A. Travis SpitzerDirector
- Raul E. PerezExecutive Officer, Director
- Arda M. MinocherhomjeeDirector
- Offering amount
- $3.2M
- Amount sold
- $1.6M
- Minimum investment
- $1K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$973.7KraisedNov 2019 · 20 investors · Other Health CareRule 506(b)
▶$973.7KraisedNov 2019 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bankim H MehtaExecutive Officer, Director
- Charlie BoltenDirector
- Danika R. HarrisonDirector
- A. Travis SpitzerDirector
- Derek H. LeeDirector
- Arda M. MinocherhomjeeDirector
- Jason A. DarrahExecutive Officer
- Ralph G. Dacey, Jr.Director
- Bevil J. HoggDirector
- Raul E. PerezDirector
- Offering amount
- $2M
- Amount sold
- $973.7K
- Minimum investment
- $25K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$912.7KraisedMar 2019 · 38 investors · Other Health CareRule 506(b)
▶$912.7KraisedMar 2019 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arda M. MinocherhomjeeDirector
- Bevil J. HoggDirector
- Ralph G. Dacey, Jr.Director
- Jason A. DarrahExecutive Officer
- Derek H. LeeDirector
- Raul E. PerezDirector
- Charles BoltenDirector
- Danika R. HarrisonExecutive Officer, Director
- A. Travis SpitzerDirector
- Offering amount
- $2M
- Amount sold
- $912.7K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$923.1KraisedAug 2018 · 25 investors · Other Health CareRule 506(b)
▶$923.1KraisedAug 2018 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- A. Travis SpitzerDirector
- Steven A. EdmundowiczExecutive Officer
- Bevil J. HoggDirector
- Charles BoltenDirector
- Jason A. DarrahExecutive Officer
- Derek H. LeeDirector
- Danika R. HarrisonExecutive Officer, Director
- Ralph G. Dacey, Jr.Director
- Arda M. MinocherhomjeeDirector
- Raul E. PerezDirector
- Offering amount
- $923.1K
- Amount sold
- $923.1K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedDec 2017 · 33 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2017 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Danika R. HarrisonExecutive Officer, Director
- Raul E. PerezDirector
- Arda M. MinocherhomjeeDirector
- Bevil J. HoggDirector
- Ralph G. Dacey, Jr.Director
- Jason A. DarrahExecutive Officer
- Steven A. EdmundowiczExecutive Officer
- A. Travis SpitzerDirector
- Charles BoltenDirector
- Derek H. LeeDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Minimum investment
- $50K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedDec 2016 · 21 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2016 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bevil J. HoggDirector
- Raul E. PerezDirector
- Derek H. LeeDirector
- Luis J. MalaveExecutive Officer
- Ralph G. DaceyDirector
- A. Travis SpitzerDirector
- Arda M. MinocherhomjeeDirector
- Jason A. DarrahExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $50K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Elira Therapeutics raised?
- Elira Therapeutics has disclosed $14M raised across 9 rounds.
- Where is Elira Therapeutics headquartered?
- Elira Therapeutics is headquartered in St. Louis, US.